Purespring Therapeutics News and Activities

Purespring Therapeutics is owned by Syncona.

Syncona is one of the...

• FTSE 350;
• TOB Iconic 10,000.

Syncona is a company listed under the stock ticker SYNC (GB).

Syncona has a direct presence in 3 countries.

Syncona has 11 subsidiaries including Anaveon, Autolus Therapeutics and Beacon Therapeutics.

They are in:

• Biotechnology83%
• Holding8%
• Other8%

Acquisition, funding and merger involving Syncona.

• Purespring Therapeutics has just announced a $105 Million fundraising (posted on March 14 2025).

View the org chart displaying its 21 main executives

Most searched biographies at Purespring Therapeutics

• Haseeb Ahmad, Chief Executive Officer
• Sonia Hallen, Director
• Chris Hollowood, Director

Popular executive movements at Purespring Therapeutics

• Julian Hanak, Chief Development Officer, has left the company  (posted on October 17 2025).

Create your alert
to follow the executive moves at Purespring Therapeutics.

Syncona has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Purespring Therapeutics

• News Archives - Purespring Therapeutics
• News & Events - Purespring Therapeutics
• Press Release Archives - Purespring Therapeutics

Social media about Purespring Therapeutics

• Purespring Therapeutics on Wikipedia, Google News & Yahoo Finance
• Purespring Therapeutics on LinkedIn, X (Twitter) & YouTube